Literature DB >> 15044507

Salivary proteins and cytokines in drug-induced gingival overgrowth.

S Ruhl1, S Hamberger, R Betz, T Sukkar, G Schmalz, R A Seymour, K-A Hiller, J M Thomason.   

Abstract

Little is known about the involvement of saliva in gingival overgrowth (GO). It was hypothesized that, in this situation, the composition of saliva is altered. Thus, proteins, albumin, cytokines, and growth factors in whole and glandular saliva were investigated. Differences between glandular and gingival contributions to the composition of saliva were explored in patients medicated with cyclosporin who exhibited GO (responders), those without GO (non-responders), and non-medicated subjects (controls). In whole saliva, interleukin-1alpha (IL-1alpha), IL-6, IL-8, epidermal growth factor (EGF), nerve growth factor (NGF), and albumin were detected, but in glandular saliva only EGF and NGF were identified. Albumin and IL-6 differed significantly between responders and controls, although the overall profile of salivary proteins remained unchanged. Thus, inflammatory cytokines and albumin are confined to whole saliva and are associated with GO, whereas its content of EGF and NGF appears unaffected by cyclosporin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044507     DOI: 10.1177/154405910408300410

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  13 in total

1.  Resting plasma and salivary IL-6 concentrations are not correlated in distance runners.

Authors:  Amanda J Cox; David B Pyne; Maree Gleson; Robin Callister
Journal:  Eur J Appl Physiol       Date:  2008-07       Impact factor: 3.078

2.  Salivary cytokine levels in subjects with chronic periodontitis and in periodontally healthy individuals: a cross-sectional study.

Authors:  R P Teles; V Likhari; S S Socransky; A D Haffajee
Journal:  J Periodontal Res       Date:  2009-02-06       Impact factor: 4.419

Review 3.  The scientific exploration of saliva in the post-proteomic era: from database back to basic function.

Authors:  Stefan Ruhl
Journal:  Expert Rev Proteomics       Date:  2012       Impact factor: 3.940

4.  Down-regulation of transforming growth factor beta-2 expression is associated with the reduction of cyclosporin induced gingival overgrowth in rats treated with roxithromycin: an experimental study.

Authors:  Simone Aparecida Probst Condé; Marcus Gomes Bastos; Beatriz Julião Vieira; Fernando Monteiro Aarestrup
Journal:  BMC Oral Health       Date:  2009-12-08       Impact factor: 2.757

Review 5.  Salivary markers of inflammation in response to acute stress.

Authors:  Danica C Slavish; Jennifer E Graham-Engeland; Joshua M Smyth; Christopher G Engeland
Journal:  Brain Behav Immun       Date:  2014-09-07       Impact factor: 7.217

6.  Expression and localization of brain-derived neurotrophic factor (BDNF) mRNA and protein in human submandibular gland.

Authors:  Juri Saruta; Kazuhiro Fujino; Masahiro To; Keiichi Tsukinoki
Journal:  Acta Histochem Cytochem       Date:  2012-06-30       Impact factor: 1.938

7.  Th1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planus.

Authors:  Nelson L Rhodus; Bin Cheng; Frank Ondrey
Journal:  Mediators Inflamm       Date:  2007-02-28       Impact factor: 4.711

Review 8.  Cyclosporine A: Novel concepts in its role in drug-induced gingival overgrowth.

Authors:  Deepa Ponnaiyan; Visakan Jegadeesan
Journal:  Dent Res J (Isfahan)       Date:  2015 Nov-Dec

9.  Association between TGFB1 genetic polymorphisms and chronic allograft dysfunction: a systematic review and meta-analysis.

Authors:  Kun Liu; Xuzhong Liu; Shuo Gu; Qing Sun; Yunyan Wang; Junsong Meng; Zongyuan Xu
Journal:  Oncotarget       Date:  2017-07-24

Review 10.  Association between interleukin-8 levels and chronic periodontal disease: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Livia S Finoti; Rafael Nepomuceno; Suzane C Pigossi; Sâmia Ct Corbi; Rodrigo Secolin; Raquel M Scarel-Caminaga
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.